More
    29 C
    Delhi
    Friday, May 3, 2024
    More

      FDA Warns Against the Use of Two Eye Drops Over Potential Bacterial and Fungal Contamination or Both

      US Food and Drug Administration (FDA) has warn consumers not to purchase and to immediately stop using Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops, Eye Repair due to bacterial contamination, fungal contamination, or for both.

      The eye drops have methylsulfonylmethane or MSM, organosulfur compounds as an active ingredient.

      As per FDA report, Dr. Berne’s has agreed to recall all its MSM Drops 5% Solution after tests show that the eye drops were contaminate with bacteria and fungus.

      While LightEyez MSM Eye Drops, Eye Repair which were found to have four types of bacteria in them hasn’t respond to the FDA’s request to discuss or recall their product.

      Dr. Berne’s MSM Drops 5% Solution was contaminate with Bacillus, Exophiala and LightEyez MSM Eye Drops, Eye Repair was contaminate with Pseudomonas, Mycobacterium, Mycolicibacterium, Methylorubrum.

      FDA recommends that consumers discard these products as using contaminate products could result in infections.

      While some of these infections could be minor but these could also turn out to be serious vision-threatening infections.

      So, if not taken proper care, it could eventually become life-threatening.

      ‘FDA conduct sampling and testing based on these products’ intend use in the eyes, and due to the industry’s recent manufacturing issues with eye drops.

      FDA’s testing show the products were contaminate with microbes and were not sterile.

      Under the Federal Food, Drug and Cosmetic Act, eye drops must be sterile to be safe for use.

      Disclaimer: Tips and suggestions mention in the article are for general information purposes only and should not be consume professional medical advice. Always consult your doctor or a dietician before starting any fitness programme or making any changes to your diet.

      ALSO READ  Bayer Launches Kerendia™ (finerenone), an Innovative Medicine to Slow Down Progression of Chronic Kidney Disease in Patients with Diabetes

      Related Articles

      LEAVE A REPLY

      Please enter your comment!
      Please enter your name here

      Stay Connected

      18,756FansLike
      80FollowersFollow
      720SubscribersSubscribe
      - Advertisement -

      Latest Articles